companies / noahlabs-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-08 json
| total_raised | 3,000,0003.0M | ○ |
|---|---|---|
| founded | 2021 | |
| hq | Berlin, Germany | |
| industry | unknown | |
| stage | null |
Noah Labs runs the Ark Class IIa telemonitoring software plus the Vox voice-biomarker algorithm that detects worsening heart failure weeks before hospitalisation. Customers include cardiology programmes managing heart failure, hypertension, and arrhythmia. Vox holds FDA Breakthrough Device designation and the company has been selected for an EIC Accelerator package of up to €11M.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-06-01 | grant | 2,700,0002.7M | null | ○ |
| fact | status | src |
|---|---|---|
| Grant, $2.7M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |